What is the protocol for infection prophylaxis in patients with myelodysplastic syndromes (MDS)?

Updated: Nov 04, 2019
  • Author: Matthew C Foster, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print


Infection prophylaxis

  • Indicated for patients with prolonged, severe neutropenia (< 0.5 × 109/L for ≥ 7 d) due to either disease or therapy, who are at risk for opportunistic infections and febrile neutropenia

  • Infection prophylaxis during periods of neutropenia should be considered with a fluoroquinolone, [20] a second-generation azole antifungal, [21] and an antiherpetic agent [22]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!